| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
178,600,000 |
| Market
Cap: |
275.04(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.8901 - $1.85 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : 7.4 |
| Insider 3/6 Months : 8 |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Precigen is a clinical-stage biopharmaceutical company improving gene and cell therapies. Co. is utilizing proprietary technology platforms to develop product candidates designed to diseases in its therapeutic areas of immuno-oncology, autoimmune disorders, and infectious diseases. Co. is developing its clinical programs, including: PRGN-3005, PRGN-3006, and PRGN-3007, which are built on its UltraCAR-T platform; PRGN-2009 and PRGN-2012, which are based on its AdenoVerse immunotherapy platform; and AG019, which is built on its ActoBiotics platform. In addition, Co. has completed a Phase 1 study of INXN-4001, a non-viral triple-effector plasmid DNA, which is built on its UltraVector platform.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
96,686 |
1,592,031 |
13,134,243 |
| Total Buy Value |
$0 |
$136,327 |
$2,615,293 |
$22,822,494 |
| Total People Bought |
0 |
1 |
4 |
8 |
| Total Buy Transactions |
0 |
1 |
6 |
12 |
| Total Shares Sold |
0 |
96,686 |
455,706 |
505,706 |
| Total Sell Value |
$0 |
$136,327 |
$650,097 |
$765,097 |
| Total People Sold |
0 |
1 |
6 |
6 |
| Total Sell Transactions |
0 |
1 |
21 |
22 |
| End Date |
2024-03-24 |
2023-12-22 |
2023-06-23 |
2022-06-23 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Nimrodi Nir |
SVP-Corporate Development |
• – – |
2017-08-11 |
4 |
B |
$18.75 |
$63,169 |
I/I |
3,369 |
7,369 |
1.99 |
- |
|
| Perez Jeffrey Thomas |
SVP, IP Affairs |
• – – |
2017-08-11 |
4 |
B |
$17.89 |
$17,890 |
D/D |
1,000 |
12,537 |
2.74 |
- |
|
| Lehr Donald P. |
Chief Legal Officer |
• – – |
2017-08-11 |
4 |
B |
$18.33 |
$20,053 |
D/D |
1,094 |
28,249 |
2.74 |
- |
|
| Mitchell Dean J |
Director |
– • – |
2017-08-11 |
4 |
B |
$18.33 |
$91,640 |
D/D |
5,000 |
18,103 |
2.39 |
- |
|
| Kirk Randal J |
Chief Executive Officer |
• • • |
2017-07-31 |
4 |
A |
$21.59 |
$999,985 |
I/I |
43,850 |
13,461,314 |
|
- |
|
| Frank Steven |
Director |
– • – |
2017-07-24 |
4 |
A |
$0.00 |
$0 |
D/D |
137,146 |
180,187 |
|
- |
|
| Alvarez Cesar L |
Director |
– • – |
2017-07-24 |
4 |
A |
$0.00 |
$0 |
D/D |
68,573 |
105,583 |
|
- |
|
| Kirk Randal J |
Chief Executive Officer |
• • • |
2017-07-24 |
4 |
A |
$0.00 |
$0 |
I/I |
16,424,238 |
8,325,000 |
|
- |
|
| Kirk Randal J |
Chief Executive Officer |
• • • |
2017-07-24 |
4 |
D |
$0.00 |
$0 |
I/I |
(22,636,052) |
0 |
|
- |
|
| Sterling Rick L. |
Chief Financial Officer |
• – – |
2017-07-07 |
4 |
OE |
$2.64 |
$180,185 |
D/D |
68,252 |
74,621 |
|
- |
|
| Kirk Randal J |
Chief Executive Officer |
• • • |
2017-06-30 |
4 |
A |
$22.82 |
$999,973 |
I/I |
43,358 |
5,352,813 |
|
- |
|
| Kirk Randal J |
Chief Executive Officer |
• • • |
2017-05-31 |
4 |
A |
$21.32 |
$999,961 |
I/I |
40,544 |
5,344,511 |
|
- |
|
| Kirk Randal J |
Chief Executive Officer |
• • • |
2017-04-28 |
4 |
A |
$19.67 |
$999,979 |
I/I |
50,267 |
5,335,131 |
|
- |
|
| Gupta Vinita D |
Director |
– • – |
2017-04-25 |
4 |
A |
$0.00 |
$0 |
D/D |
2,839 |
2,839 |
|
- |
|
| Kirk Randal J |
Chief Executive Officer |
• • • |
2017-03-31 |
4 |
A |
$19.82 |
$999,980 |
I/I |
47,897 |
5,325,535 |
|
- |
|
| Turley James S |
Director |
– • – |
2017-03-16 |
4 |
A |
$0.00 |
$0 |
D/D |
3,274 |
9,595 |
|
- |
|
| Mitchell Dean J |
Director |
– • – |
2017-03-16 |
4 |
A |
$0.00 |
$0 |
D/D |
3,274 |
13,103 |
|
- |
|
| Shapiro Robert B |
Director |
– • – |
2017-03-16 |
4 |
A |
$0.00 |
$0 |
D/D |
3,274 |
43,157 |
|
- |
|
| Frank Steven |
Director |
– • – |
2017-03-16 |
4 |
A |
$0.00 |
$0 |
D/D |
2,806 |
43,041 |
|
- |
|
| Kindler Jeffrey B |
Director |
– • – |
2017-03-16 |
4 |
A |
$0.00 |
$0 |
D/D |
3,507 |
66,322 |
|
- |
|
| Hassan Fred |
Director |
– • – |
2017-03-16 |
4 |
A |
$0.00 |
$0 |
D/D |
2,806 |
9,706 |
|
- |
|
| Kirk Randal J |
Chief Executive Officer |
• • • |
2017-01-31 |
4 |
A |
$21.16 |
$999,980 |
I/I |
41,748 |
5,306,661 |
|
- |
|
| Kirk Randal J |
Chief Executive Officer |
• • • |
2016-12-30 |
4 |
A |
$24.30 |
$999,964 |
I/I |
36,418 |
5,297,210 |
|
- |
|
| Perez Jeffrey Thomas |
SVP, IP Affairs |
• – – |
2016-12-21 |
4 |
OE |
$19.60 |
$99,980 |
D/D |
5,101 |
11,537 |
|
- |
|
| Sterling Rick L. |
Chief Financial Officer |
• – – |
2016-12-20 |
4 |
OE |
$2.65 |
$7,950 |
D/D |
3,000 |
6,369 |
|
- |
|
689 Records found
|
|
Page 22 of 28 |
|
|
0.01 (0.65%) 
